SCHEMBL4282937

SCHEMBL4282937

CCCCCCCC(O)Br

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.54
PPARD Q03181 1/20 0.54
ZDHHC20 Q5W0Z9 1/20 0.54
ZDHHC2 Q9UIJ5 1/20 0.54
GPR84 Q9NQS5 7/20 0.50
LMNA P02545 2/20 0.50
SPHK1 Q9NYA1 2/20 0.50
FFAR1 O14842 2/20 0.50
ZDHHC7 Q9NXF8 1/20 0.48
CYP2D6 P10635 2/20 0.46
GMNN O75496 1/20 0.46
POLB P06746 1/20 0.46
THPO P40225 1/20 0.46
MTOR P42345 1/20 0.46
BLM P54132 1/20 0.46
KDM4E B2RXH2 1/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29021939 1.00 LCK (0.54) LCKPPARDZDHHC20ZDHHC2GPR84
SCHEMBL28639946 1.00 LCK (0.54) LCKPPARDZDHHC20ZDHHC2GPR84
SCHEMBL28443444 1.00 LCK (0.54) LCKPPARDZDHHC20ZDHHC2GPR84
SCHEMBL2934539 1.00 LCK (0.54) LCKPPARDZDHHC20ZDHHC2GPR84
SCHEMBL1579998 1.00 LCK (0.54) LCKPPARDZDHHC20ZDHHC2GPR84
SCHEMBL28655998 1.00 LCK (0.54) LCKPPARDZDHHC20ZDHHC2GPR84
SCHEMBL1816629 1.00 LCK (0.54) LCKPPARDZDHHC20ZDHHC2GPR84
SCHEMBL5888663 1.00 LCK (0.54) LCKPPARDZDHHC20ZDHHC2GPR84
SCHEMBL6141035 1.00
SCHEMBL9158434 1.00 LCK (0.54) LCKPPARDZDHHC20ZDHHC2GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118221683-A Near infrared II region probe of targeted translocator and preparation method and application thereof 中国药科大学 2024-06-21 CN claimed
CN-110343079-B Preparation method and application of azobenzene monomer capable of Diels-Alder addition reaction 常州大学 2022-05-17 CN claimed
CN-105602346-B A kind of fluoresent printing ink and preparation method thereof 北京化工大学 2018-10-23 CN claimed
CN-105602346-A Ultraviolet fluorescent ink and preparation method thereof UNIV BEIJING CHEMICAL TECH 2016-05-25 CN claimed
CN-104177256-B The synthetic method of a kind of sex pheromone of Grapholitha molesta (Z/E)-8-dodecylene acetate SHANXI AGRICULTURAL UNIVERSITY (CN) 2016-05-25 CN claimed
CN-105218361-A A kind of synthetic method of dodecylene alcohol acetic ester SHIJAZHUANG ZHONGSHUO PHARMACEUTICAL CO LTD 2016-01-06 CN claimed
CN-104177256-A Synthesis method of grapholitha molesta sex pheromone (Z/E)-8-dodecene acetate UNIV SHANXI AGRICULTURAL 2014-12-03 CN claimed
CN-103204837-A A photodegradable crosslinking agent and a preparation method and applications thereof ZHANGJIAGANG KABANG NEW MATERIALS CO LTD 2013-07-17 CN claimed
US-20250270193-A1 ARYLIMIDAMIDES FOR USE IN TREATMENT OF CANCERS OHIO STATE INNOVATION FOUNDATION 2025-08-28 US disclosed
CN-118994203-A Preparation method and application of oligomer receptor photovoltaic material based on ester alkyl connection 北京化工大学 2024-11-22 CN disclosed
US-12059407-B2 Compositions and methods for delivery of macromolecules THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-08-13 US disclosed
CN-118221683-A Near infrared II region probe of targeted translocator and preparation method and application thereof 中国药科大学 2024-06-21 CN disclosed
US-11938233-B2 1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereof UNIVERSITÄTSKLINIKUM REGENSBURG (DE) 2024-03-26 US disclosed
WO-2023069613-A1 ARYLIMIDAMIDES FOR USE IN TREATMENT OF CANCERS OHIO STATE INNOVATION FOUNDATION (US) 2023-04-27 WO disclosed
US-5237113-A Preparation of haloalcohols BASF ALTIENGESELLSCHAFT (DE) 1993-08-17 US disclosed
US-5162367-A Arylalkadienamide THE WELLCOME FOUNDATION LIMITED (GB) 1992-11-10 US disclosed
EP-0251472-B1 PESTICIDAL UNSATURATED LIPID AMIDES THE WELLCOME FOUNDATION LIMITED (GB) 1991-04-17 EP disclosed
US-4973765-A Preparation of dien-1-ols, 9-hydroxydodec-10-enyl 1-tert-butyl ether and use thereof as an intermediate for synthesizing 8,10-dodecadienol BASF AKTIENGESELLSCHAFT (DE) 1990-11-27 US disclosed
US-4925991-A CATALYSIS BASF AKTIENGESELLSCHAFT (DE) 1990-05-15 US disclosed
EP-0251472-A2 Pesticidal unsaturated lipid amides THE WELLCOME FOUNDATION LIMITED (GB) 1988-01-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250270193-A1 ARYLIMIDAMIDES FOR USE IN TREATMENT OF CANCERS PAICS, ABL1, BCR LCK 178/4885PPARD 1033/4885ZDHHC20 1657/4885
US-12059407-B2 Compositions and methods for delivery of macromolecules CHMP4B, MTREX, NSF LCK 2183/4885PPARD 4065/4885ZDHHC20 1616/4885
US-11938233-B2 1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereof DHPS, SQLE, CYP51A1 LCK 2840/4885PPARD 2727/4885ZDHHC20 649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.